Using Adenoviruses to Fight Cancer
In the second of a 2-part series, we discuss how adenoviruses are being developed to treat cancer and some of the hurdles these platforms face from our own immune systems. Curing cancer is one of the biggest challenges of the 21st century. Our knowledge of cancer’s...
Repurposing Adenoviruses as Vectors for Vaccines
In the first of a 2-part series, we explore what makes adenoviruses so useful in gene therapy applications and how they are being developed as vectors for vaccines at the Jenner Institute in Oxford. Adenoviruses (ADVs) are non-enveloped icosahedral DNA viruses...
New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies
In September 2018 The Native Antigen Company and Virology Research Services (VRS) were awarded the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) to test a large panel of our viral antibodies in immunofluorescence applications. This...
Our Contract Services
How can we help with your project? While we are best known for our antigen and antibody products, our team has decades of experience in the field of native antigen and recombinant protein contract research, process development and bespoke production. We can undertake...